← Leaderboards
Valerie C. Pierre
University Of Minnesota
$2,593,253
Attributed
$2,593,253
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $401.5K · FY2016–24$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,593,253 · 3
By mechanism
R01$1,791,854 · 1
R21$431,075 · 1
R56$370,324 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Structure”
- David Heimbrook · Leidos Biomedical Research, Inc.$475,333,582
- Barton F Haynes · Duke University$444,977,767
- Lawrence Corey · Fred Hutchinson Cancer Center$334,646,086
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$315,257,203
Research focus
StructurePharmaceutical PreparationsPropertyBloodInnovationFamilyPublic HealthBaseReceptorPolymersIn VivoCardiovascular SystemDialysis ProcedureDialysis PatientsBlood VesselsCalcificationCationsDietary RestrictionBicarbonatesCompliance BehaviorAffinityBindingComplexDendrimers
Grant awards (8)
Immobilized phosphate receptors for the treatment of hyperphosphatemia$385,454
R01 · FY2024 · DK · contact PI
Immobilized phosphate receptors for the treatment of hyperphosphatemia$401,514
R01 · FY2023 · DK · contact PI
Immobilized phosphate receptors for the treatment of hyperphosphatemia$330,492
R01 · FY2022 · DK · contact PI
Immobilized phosphate receptors for the treatment of hyperphosphatemia$330,492
R01 · FY2021 · DK · contact PI
Immobilized phosphate receptors for the treatment of hyperphosphatemia$343,902
R01 · FY2020 · DK · contact PI
Siderophore-targeting polymeric antibtiotics$370,324
R56 · FY2018 · AI · contact PI
Antibiotics targeting siderophore receptors$190,335
R21 · FY2017 · AI · contact PI
Antibiotics targeting siderophore receptors$240,740
R21 · FY2016 · AI · contact PI